None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Inclusion criteria: Adults aged 30-60 years without recent AMI or stroke, with any of the three markers of metabolic syndrome; prehypertension, prediabetes and central obesity or dyslipidemia. Criteria of diagnosis. Prehypertension would be considered in presence of systolic BP 130-139 mm HG and diastolic 85-89 mm Hg. Pre-diabetes would be considered in presence of fasting blood glucose 110-125 mg/dl. Central obesity would be considered in presence of waste circumference of 100 mm in women and 90 mm among men.
Exclusion criteria
Exclusion criteria: Exclusion criteria: cancer, chronic dysentery, HIV
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary: Effects of h2 magnesium tablets on various markers of metabolic syndrome; blood pressures, blood glucose and central obesity,triglycerides and HDL cholesterol as well as hsCRP along with parameters of oxidative stress; TBARS,MDA, diene conjugatesTimepoint: Baseline After 4 weeks After 12 weeks After 24 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary: effects on IL-6,IL-1,TNF-alpha,IL-10, NFkbeta, MMPs,leptin, cortisolTimepoint: Baseline and after 12 or 24 weeks,if funds available | — |
Countries
India, Slovakia
Contacts
Halberg Hospital and research Institute